Atopic dermatitis mechanism and therapies (Homo sapiens)
From WikiPathways
Description
No description
Quality Tags
Ontology Terms
Pathway Ontology : regulatory pathway
Bibliography
- Song A, Lee SE, Kim JH; ''Immunopathology and Immunotherapy of Inflammatory Skin Diseases.''; Immune Netw, 2022 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name ![]() | Type ![]() | Database reference ![]() | Comment ![]() |
---|---|---|---|
Abrocitinib | Metabolite | DB14973 (DrugBank) ![]() | |
Allergen | Metabolite | CHEBI:50904 (ChEBI) ![]() | |
Baricitinib | Metabolite | DB11817 (DrugBank) ![]() | |
Barrier dysfunction | |||
CRLF2 | GeneProduct | ENSG00000292363 (Ensembl) ![]() | "TSLPR" originally |
DEFB103A | GeneProduct | ENSG00000176797 (Ensembl) ![]() | "AMPs (e.g., human β-defensin 3) are decreased in keratinocytes in response to IL-4 and IL-13." |
DEFB103B | GeneProduct | ENSG00000177243 (Ensembl) ![]() | "AMPs (e.g., human β-defensin 3) are decreased in keratinocytes in response to IL-4 and IL-13." |
Delgocitinib | Metabolite | DB16133 (DrugBank) ![]() | |
Dupilumab | Metabolite | DB12159 (DrugBank) ![]() | |
Environmental factors | |||
FCER1A | GeneProduct | ENSG00000179639 (Ensembl) ![]() | "FCER1" in source |
FCER1G | GeneProduct | ENSG00000158869 (Ensembl) ![]() | "FCER1" in source |
Genetic predisposition | |||
IGHE | GeneProduct | ENSG00000211891 (Ensembl) ![]() | "IgE" in source |
IL13 | GeneProduct | ENSG00000169194 (Ensembl) ![]() | |
IL13RA1 | GeneProduct | ENSG00000131724 (Ensembl) ![]() | |
IL1RL1 | GeneProduct | ENSG00000115602 (Ensembl) ![]() | "IL33R" in source |
IL25 | GeneProduct | ENSG00000166090 (Ensembl) ![]() | |
IL2RG | GeneProduct | ENSG00000147168 (Ensembl) ![]() | "CD132" in source |
IL31RA | GeneProduct | ENSG00000164509 (Ensembl) ![]() | |
IL33 | GeneProduct | ENSG00000137033 (Ensembl) ![]() | |
IL4 | GeneProduct | ENSG00000113520 (Ensembl) ![]() | |
IL4R | GeneProduct | ENSG00000077238 (Ensembl) ![]() | "IL4RA" originally |
IL5 | GeneProduct | ENSG00000113525 (Ensembl) ![]() | |
Itch | |||
JAK1 | GeneProduct | ||
JAK3 | GeneProduct | ENSG00000105639 (Ensembl) ![]() | |
MS4A2 | GeneProduct | ENSG00000149534 (Ensembl) ![]() | "FCER1" in source |
Nemolizumab | Metabolite | DB15252 (DrugBank) ![]() | |
OSMR | GeneProduct | ENSG00000145623 (Ensembl) ![]() | |
Ruxolitinib | Metabolite | DB08877 (DrugBank) ![]() | |
S. aureus | |||
S. epidermidis | |||
STAT3 | GeneProduct | ENSG00000168610 (Ensembl) ![]() | |
STAT6 | GeneProduct | ENSG00000166888 (Ensembl) ![]() | |
Scratch | |||
TSLP | GeneProduct | ENSG00000145777 (Ensembl) ![]() | |
TYK2 | GeneProduct | ENSG00000105397 (Ensembl) ![]() | |
Tralokinumab | Metabolite | DB12169 (DrugBank) ![]() | |
Upadacitinib | Metabolite | DB15091 (DrugBank) ![]() |
Annotated Interactions
No annotated interactions